Further, the expense of treatment was the most noteworthy for patients in CKD stage 5 in correlation with those in CKD stages till 4, as majority of the patients in CKD 5 phase were on dialysis and needed erythropoietin additionally to alternative medicines. Here, EPO is linked to chronic kidney disease.